Clinical Trial Update: Venetoclax + Azacitidine vs. Induction Chemotherapy in AML [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing venetoclax plus azacitidine versus induction chemotherapy in acute myeloid leukemia, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Venetoclax (venetoclax)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: RECRUITING